A new ACC Scientific Statement focused on the management of atherosclerotic cardiovascular disease, aims to help clinicians overcome the perpetual challenge of balancing the risk of ischemia with the ...

CMS has proposed ending Coverage with Evidence Development (CED) requirements for patients with symptomatic severe aortic stenosis (AS) while expanding CED to include patients with asymptomatic severe ...

Learn and stay certified — all in one program: The CMP blends continuous learning with assessment, making it an efficient, effective way to grow your expertise while maintaining your credentials.

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. Lipid Manager helps clinicians reduce ASCVD risk by managing patients' LDL-C and ...

The ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians, scientists and professionals. The ACC's Internal Medicine Cardiology and Pediatric Residents ...

Artificial intelligence (AI) and digital technology advances have emerged as catalysts for changing how we diagnose, treat and manage patients. The following collection of AI resources has been ...

ACC's Strategic Plan positions the College and its members for success in achieving the ACC's Mission to transform cardiovascular care and improve heart health for all as cardiovascular disease ...

When compared with liberal oxygen therapy, conservative oxygen therapy did not improve rates of survival with favorable functional outcomes among unresponsive patients in the intensive care unit (ICU) ...

A quick, noninvasive toe-based light measurement combined with artificial intelligence demonstrated efficacy in screening for peripheral artery disease (PAD), according to a recent study published in ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis ...

Both stylet-driven and non-stylet-driven leads for conduction system pacing (CSP) exhibited high implant success and low complication rates, highlighting the safety and effectiveness of both lead ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators ...